Table 4: Summary of antidiabetic therapy and blood glucose testing in the (A) dual classified, (B) POMR-only, (C) EOMR-only and (D) unclassifiable patient groups (Treatment categories are not mutually exclusive)

	Algorithm identifying people with possible diabetes
	(A) Both		(B) POMR only		(c) EOMR only		(D) Not classified		Total
Therapy group	n	%	n	%	n	%	n	%	n	%
Insulin only	7940	9.0	1288	13.4	0	0	49	2.2	9277	9.2
Insulin & OAD	11,476	13.0	1634	17.0	0	0	45	2.0	13,155	13.1
Insulin & Metformin	2198	2.5	397	4.1	0	0	14	0.6	2609	2.6
Insulin Px	21,614	24.5	3319	34.6	0	0	108	4.8	25,041	24.9
OAD Px	70,398	79.9	8723	91.0	0	0	273	12.2	79,394	79.0
DM tests only	5174	5.9	621	6.5	0	0	20	0.9	5815	5.8
Receiving DM Px	75,572	85.7	9344	97.5	0	0	293	13.1	85,209	84.8
Not receiving DM Px	12,581	14.3	243	2.5	528	100	1952	86.9	15,304	15.2
Total	88,153	100.0	9587	100.0	528	100	2245	100.0	100,513	100.0

DM=diabetes mellitus; Px=prescribed, i.e. computer record of a prescription issue.